NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
NRx Pharmaceuticals priced a public offering of 5,714,286 shares at $3.50 per share, generating gross proceeds of approximately $20 million. Underwriters were granted a 30-day option to purchase up to 857,142 additional shares, which would raise an additional $3 million if exercised in full.
Key figures
- Deal Value Usd
- 20000000
- Offering Price
- 3.5
- Shares Offered
- 5714286
- Option shares
- 857142
- Option proceeds usd
- 3000000
- Total proceeds with option usd
- 23000000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.